Tuesday, August 4, 2026

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Analysts Warn North Korea Is Recasting Its Military Strategy Around Drones and Russia Ties

Analysts urge close monitoring of North Korea's military strategy, emphasizing modernization and lessons from global conflicts.

LG Energy Solution Extends Investment Timeline: How Will It Impact EV Market in 2026?

LG Energy Solution is delaying U.S. investments amid EV demand slump and rising rates, extending deadlines to navigate market challenges.

Tag: Ali Larijani

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.